protein kinase c without lipid activator Schematic isozyme signalling pathways and downstream Frontiers | Protein Kinase C
Description
Aim This review aims to provide an integrated synthesis that bridges mechanistic evidence (anti-inflammatory, antioxidant) with clinical outcomes (mortality, arrhythmias) for LC supplementation in CAD, while critically appraising inconsistencies across the literature (e.g., heart failure, reinfarction)

[DOI] [PMC free article] [PubMed] [Google Scholar] 83.Asadi M., Rahimlou M., Shishehbor F., Mansoori A

[30-34] Need for routine molecular testing in confirmed SUM, especially in advanced or metastatic disease, to identify actionable mutations

Genau hier ordnet sich L-Carnitin ein als Ergnzung, nicht als Ersatz
